Tech Company Financing Transactions
Evvy Funding Round
Evvy, based in New York, secured $40 million in funding from Catalio Capital Management, Alumni Ventures and Amboy Street Ventures.
Transaction Overview
Company Name
Announced On
9/15/2026
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds to validate new AI-driven diagnostic and care models across women's health conditions, starting with fertility, expand distribution through physician and partner channels, and deepen its collaboration with US Fertility.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
169 Madison Avenue 2064
New York, NY 10016
USA
New York, NY 10016
USA
Phone
Undisclosed
Website
Email Address
Overview
Evvy is unlocking precision women's healthcare through novel, overlooked female biomarkers -- starting with the vaginal microbiome. Backed by leading healthcare investors such as General Catalyst, Left Lane Capital, and LabCorp, the Evvy team includes leading OB/GYNs and vaginal microbiome researchers with decades of experience at organizations like UCSF, Stanford, Harvard, Cleveland Clinic, and more. Evvy is one of the fastest growing women's health companies in the US -- enabling us to deliver innovative, high quality care while scaling novel R&D to unlock a new, data-driven future in women's health.
Management Team
Browse more venture capital transactions:
Prev: 9/15/2026: Samson Sky venture capital transaction
Next: 9/15/2026: RegCell venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC investment data records on this site come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs








